Prognostic significance of diastolic blood pressure in patients with heart failure with preserved ejection fraction.
Aya FuchidaSho SuzukiHirohiko MotokiYusuke KanzakiTakuya MaruyamaNaoto HashizumeAyako KozukaKumiko YahikozawaKoichiro KuwaharaPublished in: Heart and vessels (2021)
Although systolic blood pressure (SBP) is routinely considered when treating acute heart failure (HF), diastolic blood pressure (DBP) is hardly been assessed in the situation. There are no previous studies regarding the predictive value of DBP in elderly patients with HF with preserved ejection fraction (HFpEF) in Japan. This study aimed to investigate the prognostic significance of DBP in patients with acute decompensated HFpEF. We analyzed data of all HFpEF patients admitted to Shinonoi General Hospital for HF treatment between July 2016 and December 2018. We excluded patients with acute coronary syndrome and severe valvular disease. Patients were divided into two groups according to their median DBP; the low DBP group (DBP ≤ 77 mmHg, n = 106) and the high DBP group (DBP > 77 mmHg, n = 100). The primary outcome was HF readmission. In 206 enrolled patients (median 86 years), during a median follow-up of 302 days, the primary outcome occurred in 48 patients. The incidence of HF readmission was significantly higher in the low DBP group (33.0% vs 18.5%, p = 0.024). In Kaplan-Meier analysis, low DBP predicted HF readmission (Log-rank test, p = 0.013). In Cox proportional hazard analysis, low DBP was an independent predictor of HF readmission after adjustment for age, sex, SBP, hemoglobin, serum albumin, serum creatinine, B-type natriuretic peptide, renin-angiotensin system inhibitors, calcium channel blockers, left ventricular ejection fraction, coronary artery disease, and whether they live alone (hazard ratio, 2.229; 95% confidence interval, 1.021-4.867; p = 0.044). Low DBP predicted HF readmission in patients with HFpEF.
Keyphrases
- ejection fraction
- blood pressure
- aortic stenosis
- acute heart failure
- left ventricular
- heart failure
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- heart rate
- cardiovascular disease
- risk factors
- metabolic syndrome
- skeletal muscle
- percutaneous coronary intervention
- deep learning
- combination therapy
- blood glucose